University Spinouts and Research Commercialisation: Funding Deep Tech from the Lab
Research-based startups face long development timelines and high capital needs. Here is how university spinouts are funded, how IP and equity are typically split, and how commercialisation differs across four regions.
Key points
- Spinouts face technical risk, long timelines and complex IP arrangements.
- Negotiate IP and equity terms with an eye on future investor appeal.
- Combine grants and non-dilutive funding with equity to manage dilution.
- Build a team that balances technical depth with commercial experience.
Some of the world’s most important companies began in university laboratories. Breakthroughs in biotechnology, materials, quantum computing, energy and artificial intelligence often emerge from academic research. But turning research into a company is difficult. Deep tech ventures face long timelines, technical risk and high capital requirements, and they must negotiate with universities over intellectual property and equity.
What makes spinouts different
University spinouts differ from typical software startups in several ways:
- Technical risk: the core technology may not yet be proven outside the lab.
- Longer timelines: development can take many years before revenue.
- Higher capital needs: labs, equipment, clinical trials and manufacturing are expensive.
- IP complexity: the university usually owns the underlying intellectual property.
- Academic founders: researchers may need to learn commercial skills or recruit business leaders.
How IP and equity are handled
Universities typically own IP created by their staff and students. To commercialise it, a spinout company licenses or acquires the IP from the university. In return, the university may receive:
- Equity in the spinout.
- Licence fees and royalties on future revenue.
- Milestone payments linked to development progress.
The share of equity taken by universities has been a subject of debate. Investors argue that high university stakes can make spinouts less attractive to investors and reduce founder incentives. Several countries have reviewed their practices to make terms more founder- and investor-friendly.
Sources of funding for spinouts
- University commercialisation funds and technology transfer offices.
- Government grants and research commercialisation programmes.
- Specialist deep tech and life sciences venture funds.
- Corporate partners seeking access to new technology.
- Angel investors with technical or industry expertise.
- Philanthropic and mission-driven investors in areas such as health and climate.
Because timelines are long, spinouts often combine non-dilutive funding with equity rounds to manage dilution.
Building the right team
Investors pay close attention to whether a spinout has the right mix of skills. Academic founders bring deep technical expertise, but many investors want to see experienced commercial leadership, either as a co-founder, CEO or board member. Clarifying the roles of academic founders, including whether they will leave the university or remain part-time, is important.
Regional approaches
Australia. Australia has strong research institutions and has invested in commercialisation through programmes such as the Medical Research Future Fund and initiatives linked to CSIRO, including the Main Sequence Ventures fund. University commercialisation offices and funds support spinouts, and the R&D Tax Incentive can significantly offset development costs for eligible companies. Australian universities have been working to simplify and standardise spinout terms.
United States. The Bayh-Dole Act of 1980 allowed universities to own and license inventions from federally funded research, which helped create the modern technology transfer system. Universities such as MIT and Stanford have long histories of successful spinouts, and specialist deep tech investors are plentiful.
Europe. The UK has strong spinout activity from universities such as Oxford, Cambridge and Imperial College London. A UK government-commissioned review published in 2023 recommended lower and more consistent university equity stakes. Across Europe, programmes such as the European Innovation Council support deep tech companies with grants and equity.
Asia. Universities including the National University of Singapore, Tsinghua University in China and leading Japanese and Korean universities have growing commercialisation programmes. Governments often provide significant support through grants and co-investment schemes.
A practical example
A hypothetical materials science spinout from an Australian university was formed to commercialise a new battery electrode coating developed in a research lab. The university agreed to license the patents exclusively in exchange for equity, a modest royalty on future sales and milestone payments tied to commercial production.
Early investors were concerned that the university’s initial equity request would leave too little for the founders and future investors, so the parties negotiated a smaller stake with anti-dilution protection only until the first priced round. The two academic founders remained part-time at the university, and the company recruited an experienced CEO from the battery industry. It combined a state government grant, a refundable R&D Tax Incentive offset and a seed round from a specialist deep tech fund to fund three years of scale-up work. By the time it approached Series A investors, it had produced commercial samples and signed a joint development agreement with a manufacturer, significantly reducing technical risk.
Frequently asked questions
How much equity do universities typically take in spinouts?
It varies widely by institution and country. Historically, some universities took large stakes, but recent reforms in several countries have pushed towards lower and more standardised stakes, particularly for software and less capital-intensive spinouts.
Can academic founders keep their university jobs?
Often, yes, at least initially. Many universities have policies allowing staff to work part-time on spinouts. Investors usually want clarity about each founder’s time commitment and may expect key founders to move into full-time roles as the company raises more capital.
Are deep tech startups attractive to venture capital?
Increasingly so. Specialist deep tech funds focus on these companies, and the potential for defensible technology and very large markets can be attractive. However, investors need to be comfortable with longer timelines and higher capital needs.
Related reading
General information only. This article does not take into account your objectives, financial situation or needs, and it is not financial product, legal or tax advice or a recommendation. Figures are from the sources named and may change. Palo Alto Syndicate is a platform, not an adviser. It does not provide investment advice or recommendations. Every investment decision is yours. Early-stage investing is high risk. You could lose all the money you put in. See how the platform works and our terms of use.